Study: Planned budget cuts would hurt drug development badly

Study: Planned budget cuts would hurt drug development badly

Drug patents frequently cite research that the NIH wouldn’t be able to fund.

NIH Budget Cuts Threaten Drug Innovation and Cancer Breakthroughs

In the corridors of Washington, a fiscal storm is brewing that could reshape the future of pharmaceutical innovation. A recent study highlighted in Ars Technica reveals how proposed budget cuts to the National Institutes of Health (NIH) might severely hamper drug development. The analysis, drawing from historical patent data, underscores that a significant portion of new drug patents relies on foundational research funded by the NIH—research tha…

NIH Funding Cuts' Impact on Drug Discovery and Development

Changes in the political climate of the United States are spilling into scientific research. While many past administrations, of both parties, supported and funded science funding and education, the current administration has enacted cuts to currently funded research upwards of 40% and the proposed budget for the 2026 fiscal year shows a 39.3% cut to NIH funding. While this may not be initially concerning to most people who may ask how this coul…